Senior Principal Scientist, Large Molecule ML Translation, AI for Drug Discovery (AIDD)
Genentech
Summary
Roche's AI for Drug Discovery (AIDD) group, part of the Computational Sciences Center of Excellence, has built strong machine learning for large molecule discovery, including developability, functional modeling and design optimization. We're looking for a scientist-leader to own the translation of these methods into portfolio use, deployment into scalable trusted workflows, and application to active gRED projects.
Job description
The Opportunity
Roche's AI for Drug Discovery (AIDD) group, part of the Computational Sciences Center of Excellence, has built strong machine learning for large molecule discovery, including developability, functional modeling and design optimization. We're looking for a scientist-leader to own the translation of these methods into portfolio use, deployment into scalable trusted workflows, and application to active gRED projects.
In this role, you will:
- Adapt and extend AIDD's ML methods (developability, functional modeling, design optimization, humanization) for portfolio use.
- Close the gap between research-stage models and what real programs need.
- Use new data sources, such as early hit-sequencing datasets and PK data, to improve models and push developability and PK considerations earlier in discovery.
- Act as the main interface with Roche platform engineering and data infrastructure (DDC) teams for model deployment.
- Turn research models into reproducible, production-ready workflows with clear interfaces, benchmarks and known failure modes.
- Lead the creation and adoption of SOPs for model integration and workflow execution across gRED and pRED.
- Apply ML to active gRED large molecule projects, especially in the hit-to-lead and lead optimization window.
- Find the gaps between what pipeline teams need and what ML delivers, and use them to steer modeling priorities.
- Set the research direction and computational strategy for ML in large molecule hit-to-lead and model deployment.
- Anticipate resource needs and align with gRED and pRED portfolio goals.
- Establish and lead new cross-functional initiatives across CS CoE and gRED, and give regular scientific and technical updates to leadership.
- Work with Antibody Engineering leads and project leaders on design and progression decisions.
- Bridge ML scientists and project teams, and champion ML tools to bench scientists.
- Develop scientists across the department and broader gRED/pRED through mentorship, career development and training programs.
- Build external visibility as a thought leader through publications, talks and organizing or chairing conferences and workshops.
- Serve on steering or governance committees across CS CoE and Genentech R&D.
Who You Are
- PhD in biophysics, structural biology, computational biology or a related field, with 12+ years of relevant industry experience in biologics discovery.
- A "straddler" who is credible at the bench, in code, on project teams, and in conversations with therapeutic area leads, with a sustained record of ML embedded directly in pipeline programs rather than only benchmarks or publications.
- Deep experience optimizing antibodies from many hits to a development candidate, regardless of hit source (de novo, phage, yeast).
- A record of leading major multi-year, cross-functional initiatives, and of designing, integrating and scaling multiple computational applications across an organization in partnership with engineering teams.
- Recognized as a leading voice in ML for biologics, inside and outside the company, through publications, talks or community leadership.
- A real commitment to mentorship and to developing scientists across teams and functions.
Requirements
- PhD in biophysics, structural biology, computational biology or a related field
- 12+ years of relevant industry experience in biologics discovery
- Sustained record of ML embedded directly in pipeline programs
- Deep experience optimizing antibodies from many hits to a development candidate
- Experience with de novo, phage, or yeast hit sources
- Record of leading major multi-year, cross-functional initiatives
- Experience designing, integrating and scaling computational applications with engineering teams
- Recognized leading voice in ML for biologics through publications, talks or community leadership
- Commitment to mentorship and developing scientists
Benefits
- Discretionary annual bonus
- Benefits package
Company overview
Genentech, founded in 1976 and now a member of the Roche Group, is widely recognized as the pioneer of the biotechnology industry. The company has been at the forefront of scientific innovation for nearly 50 years, using human genetic information to develop novel medicines for serious and life-threatening diseases. Genentech's transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. With over 10,000 employees, the company operates from its South San Francisco headquarters and maintains a strong focus on oncology, immunology, neuroscience, ophthalmology, and infectious diseases. Genentech continues to pursue groundbreaking science while maintaining its startup spirit within the Roche organization, consistently delivering on its promise to improve patients' lives through innovative biopharmaceutical solutions.